
PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW128400 |
drug action
Sulfacetamide Action PathwayEscherichia coli (strain K12)
Sulfacetamide is an anti-infective agent from the sulfonamide drug class (antibiotic). This drug can be used topically to treat skin infections (acne vulgaris), as well as orally to treat urinary tract infections. It is also indicated in the treatment of bacterial vaginitis, keratitis, acute conjunctivitis, and blepharitis. Sulfacetamide is a bacteriostatic drug, it stops the replication of the bacteria. This molecule binds to the dihydropteroate synthase protein in a wide-spectrum activity against most gram-positive and many gram-negative organisms. The inhibited enzyme is essential for the synthesis of folic acid from para-aminobenzoic acid (PABA) molecules. Folic acids are essential for the growth of the bacteria.
|
Creator: Daphnee Created On: August 28, 2023 at 10:06 Last Updated: August 28, 2023 at 10:06 |
PW132601 |
Sulfacetamide Drug MetabolismHomo sapiens
Sulfacetamide is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Sulfacetamide passes through the liver and is then excreted from the body mainly through the kidney.
|
Creator: Ray Kruger Created On: September 21, 2023 at 22:35 Last Updated: September 21, 2023 at 22:35 |
PW144748 |
drug action
Sulfacetamide Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:20 Last Updated: October 07, 2023 at 14:20 |
PW128407 |
drug action
Sulfacytine Action PathwayEscherichia coli (strain K12)
Sulfacytine is a short-acting antibiotic from the sulfonamide drug class. This drug class consists of synthetic bacteriostatic antibiotics with a broad spectrum against most gram-positive and many gram-negative organisms. Sulfacytine is indicated in the treatment of acute urinary tract infections. Sulfacytine inhibits the multiplication of bacteria by acting as a competitive inhibitor of dihydropteroate synthase in the folic acid metabolism cycle. This enzyme does the condensation of the pteridine with the para-aminobenzoic acid (PABA). The inhibition causes the bacteria to stop growing. This drug is administered as an oral tablet but was discontinued in 2006 (FDA).
|
Creator: Daphnee Created On: August 28, 2023 at 11:29 Last Updated: August 28, 2023 at 11:29 |
PW145365 |
drug action
Sulfacytine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:40 Last Updated: October 07, 2023 at 15:40 |
PW144485 |
drug action
Sulfadiazine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 13:43 Last Updated: October 07, 2023 at 13:43 |
PW176136 |
Sulfadiazine Predicted Metabolism Pathway newHomo sapiens
Metabolites of Sulfadiazine are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 14:14 Last Updated: November 29, 2023 at 14:14 |
PW145662 |
drug action
Sulfadimethoxine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:20 Last Updated: October 07, 2023 at 16:20 |
PW176356 |
Sulfadimethoxine Predicted Metabolism PathwayHomo sapiens
Metabolites of sildenafil are predicted with biotransformer.
|
Creator: Omolola Created On: December 07, 2023 at 15:29 Last Updated: December 07, 2023 at 15:29 |
PW145366 |
drug action
Sulfadoxine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:40 Last Updated: October 07, 2023 at 15:40 |